Moreover, Zhang et al. [13] demonstrated that male patients with stage II/III NPC, blood group A and high immunoglobulin A antibodies to EBV viral capsid antigen (VCA-IgA) level had a favorable prognosis. The gene discussed is CD79A; the disease is nasopharyngeal carcinoma.